{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:34:42Z","timestamp":1772757282205,"version":"3.50.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>CD40 is present on both normal and neoplastic B-lineage cells. CD40 stimulation of normal B cells has been shown to promote normal growth and differentiation, whereas aggressive histology B lymphomas are growth inhibited. The inhibition of neoplastic B-cell growth is believed to occur via activation-induced cell death in which stimuli that typically promote the growth of normal cells prevent the growth of their neoplastic counterparts. We show here that CD40 stimulation using either a soluble recombinant human CD40 ligand (srhCD40L) or anti-CD40 monoclonal antibody resulted in apoptosis of human Burkitt lymphoma cell lines. Additional studies examining the mechanism of CD40-mediated death revealed an increase in bax messenger RNA with a subsequent increase in Bax protein in the mitochondria of the treated cells. In vitro exposure of the cells to bax antisense oligonucleotides resulted in a significant decline in Bax protein levels and partial protection from CD40-mediated death, indicating that induction of Bax was at least one mechanism underlying this inhibitory effect of CD40 stimulation on lymphomas. When immunodeficient mice bearing Burkitt lymphoma were treated with srhCD40L, significant increases in survival were observed indicating a direct antitumor effect as a result of CD40 stimulation in vivo. Overall, these results demonstrate that CD40 ligation of aggressive histology B-lymphoma cells results in inhibition both in vitro and in vivo and thus may be of potential clinical use in their treatment.<\/jats:p>","DOI":"10.1182\/blood.v100.1.217","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:48:18Z","timestamp":1033508898000},"page":"217-223","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax"],"prefix":"10.1182","volume":"100","author":[{"given":"Jamie L.","family":"Szocinski","sequence":"first","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette R.","family":"Khaled","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Hixon","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Halverson","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Funakoshi","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Fanslow","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Boyd","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Taub","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott K.","family":"Durum","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clay B.","family":"Siegall","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan L.","family":"Longo","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[{"name":"From the Laboratory of Leukocyte Biology, Laboratory of Molecular Immunoregulation, and SAIC-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland; Laboratory of Immunology, National Institute on Aging, Baltimore, Maryland; Immunex Corporation, Seattle, Washington; Biology Department, Hood College, Frederick, Maryland; and Seattle Genetics, Bothell, Washington."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021223013779700_B1","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1073\/pnas.83.12.4494","article-title":"Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.","volume":"83","author":"Clark","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021223013779700_B2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","article-title":"The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death.","volume":"76","author":"Smith","year":"1994","journal-title":"Cell."},{"key":"2020021223013779700_B3","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V83.10.2787.2787","article-title":"Inhibition of human B-cell lymphoma growth by CD40 stimulation.","volume":"83","author":"Funakoshi","year":"1994","journal-title":"Blood."},{"key":"2020021223013779700_B4","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1002\/j.1460-2075.1992.tb05530.x","article-title":"The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.","volume":"11","author":"Hollenbaugh","year":"1992","journal-title":"EMBO J."},{"key":"2020021223013779700_B5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<795::AID-IJC18>3.0.CO;2-#","article-title":"Expression of the co-stimulatory molecule CD40 on melanoma cells.","volume":"68","author":"Thomas","year":"1996","journal-title":"Int J Cancer."},{"key":"2020021223013779700_B6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/357080a0","article-title":"Molecular and biological characterization of a murine ligand for CD40.","volume":"357","author":"Armitage","year":"1992","journal-title":"Nature."},{"key":"2020021223013779700_B7","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/eji.1830230941","article-title":"CD40 ligand is a T cell growth factor.","volume":"23","author":"Armitage","year":"1993","journal-title":"Eur J Immunol."},{"key":"2020021223013779700_B8","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/eji.1830221226","article-title":"Cloning of TRAP, a ligand for CD40 on human T cells.","volume":"22","author":"Graf","year":"1992","journal-title":"Eur J Immunol."},{"key":"2020021223013779700_B9","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1074\/jbc.274.1.418","article-title":"Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154).","volume":"274","author":"Morris","year":"1999","journal-title":"J Biol Chem."},{"key":"2020021223013779700_B10","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1182\/blood.V92.8.2830","article-title":"Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma on short-term exposure to CD40 ligand.","volume":"92","author":"Baker","year":"1998","journal-title":"Blood."},{"key":"2020021223013779700_B11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2567.1998.00550.x","article-title":"Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.","volume":"94","author":"Vyth-Dreese","year":"1998","journal-title":"Immunology."},{"key":"2020021223013779700_B12","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.4049\/jimmunol.144.7.2550","article-title":"Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones.","volume":"144","author":"Umetsu","year":"1990","journal-title":"J Immunol."},{"key":"2020021223013779700_B13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V82.6.1848.1848","article-title":"Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40\/stromal cell system.","volume":"82","author":"Johnson","year":"1993","journal-title":"Blood."},{"key":"2020021223013779700_B14","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1182\/blood.V84.9.3134.3134","article-title":"Proliferation and cytogenic analysis of hairy cell leukemia upon stimulation via the CD40 antigen.","volume":"84","author":"Kluin-Nelemans","year":"1994","journal-title":"Blood."},{"key":"2020021223013779700_B15","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V80.12.3173.3173","article-title":"Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.","volume":"80","author":"Fluckiger","year":"1992","journal-title":"Blood."},{"key":"2020021223013779700_B16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199709039007","article-title":"Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis.","volume":"24","author":"Funakoshi","year":"1997","journal-title":"Leuk Lymphoma."},{"key":"2020021223013779700_B17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0952-7915(97)80078-7","article-title":"Functions of CD40 on B cells, dendritic cells and other cells.","volume":"9","author":"Van-Kooten","year":"1997","journal-title":"Curr Opin Immunol."},{"key":"2020021223013779700_B18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00002371-199603000-00002","article-title":"Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.","volume":"19","author":"Funakoshi","year":"1996","journal-title":"J Immunother."},{"key":"2020021223013779700_B19","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood.V83.5.1329.1329","article-title":"Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing growth arrest.","volume":"83","author":"Ghetie","year":"1994","journal-title":"Blood."},{"key":"2020021223013779700_B20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V83.8.2045.2045","article-title":"Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.","volume":"83","author":"Gruss","year":"1994","journal-title":"Blood."},{"key":"2020021223013779700_B21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1357-2725(98)00006-5","article-title":"Molecules in focus Bax. The pro-apoptotic Bcl-2 family member, Bax [review].","volume":"30","author":"Brady","year":"1998","journal-title":"Int J Biochem Cell Biol."},{"key":"2020021223013779700_B22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1083\/jcb.139.5.1281","article-title":"Movement of Bax from the cytosol to the mitochondria during apoptosis.","volume":"169","author":"Wolter","year":"1997","journal-title":"J Cell Biol."},{"key":"2020021223013779700_B23","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1073\/pnas.96.25.14476","article-title":"Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise of intracellular pH.","volume":"96","author":"Khaled","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021223013779700_B24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.277.5324.370","article-title":"Inhibition of Bax channel-forming activity by Bcl-2.","volume":"277","author":"Antonnson","year":"1997","journal-title":"Science."},{"key":"2020021223013779700_B25","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1074\/jbc.275.10.7337","article-title":"p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release.","volume":"275","author":"Schuler","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021223013779700_B26","first-page":"3099","article-title":"Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen.","volume":"55","author":"Fransisco","year":"1995","journal-title":"Cancer Res."},{"key":"2020021223013779700_B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199609067572","article-title":"CD40 and the effect of anti-CD40-binding on human multiple myeloma clonogenicity.","volume":"21","author":"Tong","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2020021223013779700_B28","first-page":"1909","article-title":"CD11a-CD18 and CD102 interactions mediate human myeloma cell growth arrest by CD40 stimulation.","volume":"56","author":"Pellat-Deceunynck","year":"1996","journal-title":"Cancer Res."},{"key":"2020021223013779700_B29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000163944","article-title":"Epstein-Barr virus induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.","volume":"63","author":"Funakoshi","year":"1995","journal-title":"Pathobiology."},{"key":"2020021223013779700_B30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2141.1997.422688.x","article-title":"Role of the CD40 and CD95 (APO-1\/Fas) antigens in the apoptosis of human B-cell malignancies.","volume":"97","author":"Wang","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021223013779700_B31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.immunol.16.1.395","article-title":"Bcl-2 family: regulators of cell death [review].","volume":"16","author":"Chao","year":"1998","journal-title":"Annu Rev Immunol."},{"key":"2020021223013779700_B32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptic response to anticancer agents.","volume":"290","author":"Zhang","year":"2000","journal-title":"Science."},{"key":"2020021223013779700_B33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell."},{"key":"2020021223013779700_B34","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood.V85.9.2461.bloodjournal8592461","article-title":"Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: inhibition of growth is associate with a downregulation of mutant p53.","volume":"85","author":"Beckwith","year":"1995","journal-title":"Blood."},{"key":"2020021223013779700_B35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.3037698","article-title":"T-cell tumor elimination as a result of T-cell receptor-mediated activation.","volume":"237","author":"Ashwell","year":"1987","journal-title":"Science."},{"key":"2020021223013779700_B36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/cimm.1993.1305","article-title":"Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells.","volume":"152","author":"Heath","year":"1993","journal-title":"Cell Immunol."},{"key":"2020021223013779700_B37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1084\/jem.164.1.156","article-title":"Lymphoma models for B cell activation and tolerance, III: cell cycle dependence for negative signaling of WEHI-231B lymphoma cells by anti-mu.","volume":"164","author":"Scott","year":"1986","journal-title":"J Exp Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/1\/217\/1683794\/h81302000217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/1\/217\/1683794\/h81302000217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T19:37:47Z","timestamp":1682365067000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/1\/217\/133971\/Activationinduced-cell-death-of-aggressive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v100.1.217","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}